Sanofi sets up a ti­tle fight with Roche in he­mo­phil­ia A — pro­vid­ed gene ther­a­pies don't beat them to the punch

Af­ter get­ting roughed up by Roche’s block­buster he­mo­phil­ia A drug Hem­li­bra, Sanofi is plan­ning to hit back with its own com­mer­cial coun­ter­punch fol­low­ing pos­i­tive Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER